Telmisartan Treatment of Refractory Proteinuria in a Dog-Reference-Cited by-同舟云学术

Telmisartan Treatment of Refractory Proteinuria in a Dog

Published:2014-09-30 Issue:6 Volume:28 Page:1871-1874
ISSN:0891-6640
Container-title:Journal of Veterinary Internal Medicine
language:en
Short-container-title:J Vet Intern Med

Author:

Bugbee A.C.¹,Coleman A.E.¹,Wang A.¹,Woolcock A.D.¹,Brown S.A.¹

Affiliation:

1. Department of Small Animal Medicine & Surgery; College of Veterinary Medicine; University of Georgia; Athens GA

Publisher

Wiley

Subject

General Veterinary

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvim.12471/fullpdf

Reference16 articles.

1. Day-to-Day variation of the urine protein: Creatinine ratio in female dogs with stable glomerular proteinuria caused by X-linked hereditary nephropathy;Nabity;J Vet Intern Med,2007

2. Assessment and management of proteinuria in dogs and cats: 2004 ACVIM Forum Consensus Statement (small animal);Lees;J Vet Intern Med,2005

3. Associations between proteinuria, systemic hypertension and glomerular filtration rate in dogs with renal and non-renal diseases;Wehner;Vet Rec,2008

4. Association of systemic hypertension with renal injury in dogs with induced renal failure;Finco;J Vet Intern Med,2004

5. Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis;Grauer;J Vet Intern Med,2000

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antihypertensives;Pharmacology in Veterinary Anesthesia and Analgesia;2024-03-08

2. Proteinuria;Urinalysis in the Dog and Cat;2023-01-27

3. The use of telmisartan in cats with chronic kidney disease in the early stages to control proteinuria;II INTERNATIONAL CONFERENCE “SUSTAINABLE DEVELOPMENT: AGRICULTURE, VETERINARY MEDICINE AND ECOLOGY”;2023

4. Single‐dose pharmacokinetics of telmisartan oral solution and effect of feeding in dogs;Journal of Veterinary Pharmacology and Therapeutics;2022-11-10

5. Telmisartan as an add-on treatment for dogs with refractory idiopathic epilepsy: a nonrandomized, uncontrolled, open-label clinical trial;Journal of the American Veterinary Medical Association;2022-04-01